US$ 25.75
converting between glp 1 agonists GLP-1 Receptor Agonists: An Alternative for Rapid-Acting Insulin? GLP-1-based therapies for type 2
Description
In: Basic & Clinical Pharmacology

Early research indicates GLP-1 households are pulling back on food and alcohol purchases more significantly than the average shopper

It also inhibits gut motility and secretion and regulates food intake

Whilst the synthesis of Romariz and colleagues supports the proposal that GLP-1 agonists are effective for weight loss in patients younger than 12, this is based only on 2 randomised controlled trials, both of which used liraglutide

The prevalence of complications associated with obesity, including dyslipidaemia, hypertension, fatty liver disease and psychosocial complications are becoming increasingly prevalent within the paediatric populations
